Ligand Pharmaceuticals Incorporated Intellectual Property Contracts & Agreements
23 Contracts & Agreements
- License Agreements (23 contracts)
- Commercial License Agreement between Taurus Biosciences, LLC and Minotaur Therapeutics, Inc., dated September 9, 2020 (Filed With SEC on September 10, 2020)
- Addendum, dated May 22, 2019, by and among Ligand Pharmaceuticals Incorporated, CyDex Pharmaceuticals, Inc. and Acrotech Biopharma LLC (as successor-in-interest to Spectrum... (Filed With SEC on August 8, 2019)
- License Agreement, dated March 5, 2018, by and between the Company and Roivant Sciences GmbH (Filed With SEC on May 9, 2018)
- SECOND AMENDMENT TO MASTER LICENSE AGREEMENT (Filed With SEC on August 5, 2015)
- FIRST AMENDMENT TO MASTER LICENSE AGREEMENT (Filed With SEC on October 31, 2014)
- LICENSE AGREEMENT Dated as of June 23, 2014 by and between Ligand Pharmaceuticals Incorporated and TG Therapeutics, Inc. LICENSE AGREEMENT (Filed With SEC on August 5, 2014)
- RESEARCH AND LICENSE AGREEMENT Dated as of May 9, 2014 by and between Ligand Pharmaceuticals Incorporated and Omthera Pharmaceuticals, Inc. RESEARCH AND LICENSE AGREEMENT (Filed With SEC on August 5, 2014)
- MASTER LICENSE AGREEMENT Dated May 21, 2014 by and between Ligand Pharmaceuticals Incorporated and Metabasis Therapeutics, Inc., on one hand, and Viking Therapeutics, Inc., on the... (Filed With SEC on August 5, 2014)
- LICENSE AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND CURX PHARMACEUTICALS, INC. DATED: August 12, 2013 TABLE OF CONTENTS (Filed With SEC on November 8, 2013)
- LICENSE AGREEMENT (Filed With SEC on November 8, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 8, 2013)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on March 14, 2013)
- RESEARCH LICENSE AND OPTION AGREEMENT Dated April 27, 2012 By and Between Ligand Pharmaceuticals Incorporated and Ares Trading SA (Filed With SEC on August 8, 2012)
- LICENSE AND SUPPLY AGREEMENT (Filed With SEC on February 23, 2012)
- LICENSE AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY DATED: December 16, 2011 TABLE OF CONTENTS (Filed With SEC on February 23, 2012)
- FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on November 8, 2011)
- LICENSE AGREEMENT (Filed With SEC on September 9, 2011)
- LICENSE AGREEMENT (Filed With SEC on August 8, 2011)
- LICENSE AGREEMENT (Filed With SEC on May 10, 2011)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on March 3, 2011)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on March 3, 2011)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on March 3, 2011)
- AMENDMENT NUMBER ONE TO RESEARCH AND LICENSE AGREEMENT (Filed With SEC on May 3, 2010)
